Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites

NCT01552590 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyponatremia and Extracellular Fluid in Cirrhotic

Interventions

DRUG: Tolvaptan
DRUG: Placebo

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.